tiprankstipranks
Entrada Therapeutics Inc (TRDA)
NASDAQ:TRDA
US Market

Entrada Therapeutics Inc (TRDA) Cash flow

Compare
88 Followers

Entrada Therapeutics Inc Cash Flow

TRDA's free cash flow for Q4 2024 was $-32.24M. For the 2024 fiscal year, TRDA's free cash flow was decreased by $-178.90M and operating cash flow was $-31.61M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -41.56M$ 139.80M$ -93.79M$ -50.86M$ -25.57M
Investing Cash Flow
$ -27.80M$ -138.40M$ -148.65M$ -4.58M$ -2.32M
Financing Cash Flow
$ 102.96M$ 21.04M$ 479.00K$ 307.46M$ 50.09M
End Cash Position
$ 105.16M$ 71.55M$ 49.11M$ 291.06M$ 39.05M
Free Cash Flow
$ -44.72M$ 134.19M$ -96.67M$ -55.44M$ -27.89M
Currency in USD

Entrada Therapeutics Inc Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis